先瑞达医疗(06669.HK)心脏瓣膜球囊扩张导管产品获批上市

阿斯达克财经
Nov 20, 2024

先瑞达医疗-B(06669.HK) 宣布,通过医工结合方式研发的心脏瓣膜球囊扩张导管产品“RunFlow”,已获国家药品监督管理局批准上市,用于在经导管主动脉瓣置换术中治疗主动脉瓣狭窄。(gc/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-19 16:25。)AASTOCKS新闻

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10